売上高・売上総利益率の推移
| 年度 |
売上高 |
売上総利益率 |
| 2024/12 |
302 |
- |
| 2023/12 |
314 |
- |
| 2022/12 |
1,772 |
- |
| 2021/12 |
2,963 |
- |
| 2020/12 |
1,050 |
- |
| 2019/12 |
4,461 |
|
| 2018/12 |
8,386 |
|
| 2017/12 |
4,003 |
|
| 2016/12 |
3,337 |
|
| 2015/12 |
2,538 |
|
| 2014/12 |
4,320 |
|
営業利益・営業利益率の推移
| 年度 |
営業利益 |
営業利益率 |
| 2024/12 |
-299,035 |
-99018.2% |
| 2023/12 |
-254,450 |
-81035.0% |
| 2022/12 |
-134,304 |
-7579.2% |
| 2021/12 |
-79,728 |
-2690.8% |
| 2020/12 |
-110,380 |
-10512.4% |
| 2019/12 |
-41,979 |
|
| 2018/12 |
-33,084 |
|
| 2017/12 |
-26,532 |
|
| 2016/12 |
-12,508 |
|
| 2015/12 |
-11,187 |
|
| 2014/12 |
-6,867 |
|
|
（単位：千ドル）
|
2014/12
|
2015/12
|
2016/12
|
2017/12
|
2018/12
|
2019/12
|
2020/12
|
2021/12
|
2022/12
|
2023/12
|
2024/12
|
|
売上高
|
4,320
|
2,538
|
3,337
|
4,003
|
8,386
|
4,461
|
1,050
|
2,963
|
1,772
|
314
|
302
|
|
売上成長率（％）
|
-
|
|
|
|
|
|
-76.5
|
182.2
|
-40.2
|
-82.3
|
-3.8
|
|
売上原価
|
3,243
|
2,472
|
2,548
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
研究開発費
|
293
|
1,002
|
888
|
19,623
|
30,421
|
34,794
|
-
|
-
|
-
|
-
|
-
|
|
営業費用
|
11,187
|
13,725
|
15,845
|
30,535
|
41,470
|
46,440
|
111,430
|
82,691
|
136,076
|
254,764
|
299,337
|
|
営業利益
|
-6,867
|
-11,187
|
-12,508
|
-26,532
|
-33,084
|
-41,979
|
-110,380
|
-79,728
|
-134,304
|
-254,450
|
-299,035
|
|
営業利益率 (%)
|
|
|
|
|
|
|
-10512.4
|
-2690.8
|
-7579.2
|
-81035.0
|
-99018.2
|
|
純利益
|
-7,890
|
-11,328
|
-12,674
|
-26,512
|
-32,703
|
-41,873
|
-110,715
|
-79,413
|
-129,874
|
-237,734
|
-269,949
|
|
純利益率（％）
|
|
|
|
|
|
|
-10544.3
|
-2680.2
|
-7329.2
|
-75711.5
|
-89387.1
|
|
一株あたり利益
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-6.66
|
-4.05
|
-5.31
|
-
|
|
希薄化後一株あたり利益
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-6.66
|
-4.05
|
-5.31
|
-
|
|
EBITDA
|
|
|
|
|
|
|
-110,180
|
-79,628
|
-134,004
|
-253,950
|
-298,535
|
|
EBITDAマージン（％）
|
|
|
|
|
|
|
-10493.3
|
-2687.4
|
-7562.3
|
-80875.8
|
-98852.6
|